Search research articles
Contact Us
Filters
Showing results (231-240 of 350) with videos related to
Page
of 35
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 29, 2020
Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis
Mahsa Abassi, Ananta S Bangdiwala, Edwin Nuwagira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2020
Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus-Associated Tuberculous Meningitis
Emily M Martyn, Ananta S Bangdiwala, Enock Kagimu, et al.
Open Forum Infectious Diseases
|
January 26, 2016
Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding
David R Boulware, Maximilian von Hohenberg, Melissa A Rolfes, et al.
Open Forum Infectious Diseases
|
February 2, 2026
Development Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases
Jose Portugal Gonzales, Neil M Ampel, David R Boulware, et al.
Wellcome Open Research
|
February 7, 2022
Host Directed Therapies for Tuberculous Meningitis
Angharad G Davis, Joseph Donovan, Marise Bremer, et al.
Open Forum Infectious Diseases
|
December 18, 2020
Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
Supavit Chesdachai, Nicole W Engen, Joshua Rhein, et al.
Open Forum Infectious Diseases
|
September 12, 2022
Therapeutic Lumbar Punctures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
Enock Kagimu, Nicole Engen, Kenneth Ssebambulidde, et al.
Antimicrobial Agents and Chemotherapy
|
August 5, 2020
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
Caleb P Skipper, Mucunguzi Atukunda, Anna Stadelman, et al.
Human Immunology
|
June 14, 2026
Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIV
Caleb P Skipper, Biyue Dai, Bruno Borges, et al.
Mycoses
|
December 20, 2018
Cryptococcal meningitis is a cause for cross-reactivity in cerebrospinal fluid assays for anti-Histoplasma, anti-Coccidioides and anti-Blastomyces antibodies
Nathan C Bahr, Anil A Panackal, Michelle M Durkin, et al.
Page
of 35
Search research articles
Search
Showing results (231-240 of 350) with videos related to
Sort By:
Page
of 35
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 29, 2020
Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis
Mahsa Abassi, Ananta S Bangdiwala, Edwin Nuwagira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2020
Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus-Associated Tuberculous Meningitis
Emily M Martyn, Ananta S Bangdiwala, Enock Kagimu, et al.
Open Forum Infectious Diseases
|
January 26, 2016
Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding
David R Boulware, Maximilian von Hohenberg, Melissa A Rolfes, et al.
Open Forum Infectious Diseases
|
February 2, 2026
Development Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases
Jose Portugal Gonzales, Neil M Ampel, David R Boulware, et al.
Wellcome Open Research
|
February 7, 2022
Host Directed Therapies for Tuberculous Meningitis
Angharad G Davis, Joseph Donovan, Marise Bremer, et al.
Open Forum Infectious Diseases
|
December 18, 2020
Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
Supavit Chesdachai, Nicole W Engen, Joshua Rhein, et al.
Open Forum Infectious Diseases
|
September 12, 2022
Therapeutic Lumbar Punctures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
Enock Kagimu, Nicole Engen, Kenneth Ssebambulidde, et al.
Antimicrobial Agents and Chemotherapy
|
August 5, 2020
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
Caleb P Skipper, Mucunguzi Atukunda, Anna Stadelman, et al.
Human Immunology
|
June 14, 2026
Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIV
Caleb P Skipper, Biyue Dai, Bruno Borges, et al.
Mycoses
|
December 20, 2018
Cryptococcal meningitis is a cause for cross-reactivity in cerebrospinal fluid assays for anti-Histoplasma, anti-Coccidioides and anti-Blastomyces antibodies
Nathan C Bahr, Anil A Panackal, Michelle M Durkin, et al.
Page
of 35